Plan B Approval Clears The Way For Von Eschenbach Confirmation

FDA's decision to approve the emergency contraceptive Plan B for over-the-counter sale to women age 18 and older opens the door to a vote on FDA Acting Commissioner Andrew von Eschenbach's nomination to the permanent post